Thomas Powles discusses the phase 3 trial investigating the use of maintenance avelumab after first-line chemotherapy in patients with advanced urothelial cancer (6:19).
01-06-2020 | ASCO 2020 | Conference coverage | Video
01-06-2020 | ASCO 2020 | Conference coverage | Video
Thomas Powles discusses the phase 3 trial investigating the use of maintenance avelumab after first-line chemotherapy in patients with advanced urothelial cancer (6:19).